Tadaaki Nishikawa

Jul 30, 2024 | acsjournals.onlinelibrary.wiley.com | Tadaaki Nishikawa |Kenji Tamura |Masashi Ando |Shigeki Kakunaga

CONFLICT OF INTEREST STATEMENT Tadaaki Nishikawa reports fees for participating on a speakers’ bureau from Chugai Pharma, Eisai, Genmab, MSD, Roche Diagnostics, Sanofi, and Takeda; and institutional research funding from AstraZeneca and Daiichi-Sankyo. Akira Kawai reports fees for participating on a speakers’ bureau and/or acting in a consulting/advisory role and institutional research funding from Boehringer Ingelheim, Taiho Pharmaceutical, and Takara Bio.